Reviewer's report 
 Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a Title: 
randomised controlled trial. 
 1  27 April 2004 Version: Date: 
 Keith D Lindor Reviewer: 
Reviewer's report: 
General 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
A few things that should be discussed in the manuscript include: 
1) How was the agent picked (known to be a sedating antidepressant)? 
2) How was the dose arrived at? 3) Was there any difference in response between men and women. 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept after minor essential revisions What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
None. 
Reviewer's report 
 Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a Title: 
randomised controlled trial. 
 1  27 April 2004 Version: Date: 
 Keith D Lindor Reviewer: 
Reviewer's report: 
General 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
A few things that should be discussed in the manuscript include: 
1) How was the agent picked (known to be a sedating antidepressant)? 
2) How was the dose arrived at? 3) Was there any difference in response between men and women. 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept after minor essential revisions What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
None. 
Please review this paper.
user
Reviewer's report 
 Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a Title: 
randomised controlled trial. 
 1  27 April 2004 Version: Date: 
 Keith D Lindor Reviewer: 
Reviewer's report: 
General 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
A few things that should be discussed in the manuscript include: 
1) How was the agent picked (known to be a sedating antidepressant)? 
2) How was the dose arrived at? 3) Was there any difference in response between men and women. 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept after minor essential revisions What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
None. 
assistant